2m 2m 2m 2m 2m 2m 2m
OS THERAP (OSTX)
NYSE
$1.82+$0.02 (+1.11%)
Price as of Jun 03, 2026 7:57 PM EDT- $95.3MMarket Cap
- 15.09%1-Year Change
- BiotechnologyIndustry
OS THERAP (OSTX)
$1.82+$0.02 (+1.11%)
OSTX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.80 | ||
Change | -$0.04 (-2.14%) | ||
Open | $1.83 | ||
High | $1.87 | ||
Low | $1.76 | ||
Previous Close | $1.83 | ||
Volume | 624,685 | ||
30-Day Average Volume | 801,792 | ||
1-Week Change | 4.57% | ||
1-Month Change | 13.66% | ||
1-Year Change | 15.09% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 44.5M | ||
Total Assets | $7.3M | ||
Market Cap | $95.3M | ||
Enterprise Value | $95.7M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$10.4M | ||
Free Cash Flow | -$4.6M | ||
EBIT | -$10.4M | ||
EBITDA | -$10.3M | ||
Net Working Capital | -$16.0M | ||
EPS | -$0.27 | ||
Enterprise Value/EBITDA | -9 | ||
Enterprise Value/Revenue | N/A | ||
P/B | -9 | ||
P/E | -8 | ||
PEG | -0 | ||
Price/Free Cash Flow | -21 | ||
Price/Operating Cash Flow | -21 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue